Literature DB >> 15010145

The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.

Anjali B Joshi1, Lee E Kirsch.   

Abstract

The major hydrolytic degradation pathways of glucagon under acidic conditions are cleavage at Asp-9, Asp-15, and Asp-21, and deamidation at Gln-3, Gln-20, Gln-24, and Asn-28. The rate constants for these pathways were determined in the pH range 1-2.4 at 60 degrees C by kinetic data analysis of substrate and degradation product concentration-time profiles. Deamidation kinetics were determined using penta-peptide fragments of glucagon containing the labile amide residue. The accurate determination of the cleavage rate constants was confounded by the complexity of the degradation scheme of glucagon. Peptide cleavage kinetics were determined by degradation of glucagon and its cleavage fragments under identical conditions and the use of area-under-the-curve (AUC) and nonlinear regression methods of analysis. Glucagon degradation was first-order with respect to time and concentration in the range of 31-00 microM. Glutaminyl deamidation rate constants were first-order with respect to hydronium ion concentration and were similar for all three residues indicating a lack of sequence effects. The rate constants for Asp cleavage were not first-order with respect to hydronium ion concentration and cleavage at Asp-21 was slower than cleavage at Asp-9 and Asp-15 over the studied pH range.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010145     DOI: 10.1016/j.ijpharm.2004.01.006

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Optimization of the native glucagon sequence for medicinal purposes.

Authors:  Joseph R Chabenne; Maria A DiMarchi; Vasily M Gelfanov; Richard D DiMarchi
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

2.  A density functional theory study on peptide bond cleavage at aspartic residues: direct vs cyclic intermediate hydrolysis.

Authors:  Wichien Sang-aroon; Vittaya Amornkitbamrung; Vithaya Ruangpornvisuti
Journal:  J Mol Model       Date:  2013-11-17       Impact factor: 1.810

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

5.  Mechanisms of glucagon degradation at alkaline pH.

Authors:  Nicholas Caputo; Jessica R Castle; Colin P Bergstrom; Julie M Carroll; Parkash A Bakhtiani; Melanie A Jackson; Charles T Roberts; Larry L David; W Kenneth Ward
Journal:  Peptides       Date:  2013-05-04       Impact factor: 3.750

6.  Protein Splicing Activity of the Haloferax volcanii PolB-c Intein Is Sensitive to Homing Endonuclease Domain Mutations.

Authors:  Shachar Robinzon; Alexandra R Cawood; Mercedes A Ruiz; Uri Gophna; Neta Altman-Price; Kenneth V Mills
Journal:  Biochemistry       Date:  2020-09-02       Impact factor: 3.162

Review 7.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

8.  Theoretical study on isomerization and peptide bond cleavage at aspartic residue.

Authors:  Wichien Sang-aroon; Vithaya Ruangpornvisuti
Journal:  J Mol Model       Date:  2013-06-11       Impact factor: 1.810

9.  A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia.

Authors:  Joseph Chabenne; Maria Dimarchi Chabenne; Yan Zhao; Jay Levy; David Smiley; Vasily Gelfanov; Richard Dimarchi
Journal:  Mol Metab       Date:  2014-01-22       Impact factor: 7.422

10.  Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli.

Authors:  Katia Pane; Lorenzo Durante; Elio Pizzo; Mario Varcamonti; Anna Zanfardino; Valeria Sgambati; Antimo Di Maro; Andrea Carpentieri; Viviana Izzo; Alberto Di Donato; Valeria Cafaro; Eugenio Notomista
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.